Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
University of Nebraska
University of Nebraska
Columbia University
Massachusetts General Hospital
Roswell Park Cancer Institute
Samsung Medical Center
Stanford University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center